Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology
Reference13 articles.
1. Cinosi E, Martinotti G, Simonato P, et al. Following “the Roots” of kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in Southeast Asia to a recreational psychoactive drug in Western countries. Biomed Res Int. 2015;2015:968786.
2. USFDA 2018: FDA objects to kratom compound intended for use as an alternative to prescription opioids and promoted with unproven claims to treat addiction. Available at: https://www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm598389.htm.
3. Smid MC, Charles JE, Gordon AJ, Wright TE. Use of kratom, an opioid-like traditional herb, in pregnancy. Obstet Gynecol. 2018;132(4):926–8.
4. Post S, Spiller HA, Chounthirath T, Smith GA. Kratom exposures reported to United States poison control centers: 2011-2017. Clin Toxicol. 2019.
5. White CM. Pharmacologic and clinical assessment of kratom. Am J Health Syst Pharm. 2018;75:261–7.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献